Most pharmaceutical digitalisation projects never progress beyond the pilot phase. AUTOMA+ 2026 is designed for the organisations determined to break that cycle. As fragmented systems, uncertain return on investment and poor operational integration continue to hinder transformation initiatives across the industry, the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026, taking place on 16–17 November in Zurich, Switzerland, will bring together the leaders, technology experts and implementation specialists focused on delivering digital transformation at scale.
Rather than concentrating on theory, the programme is built around practical, real-world implementation. Delegates will hear directly from organisations that have successfully deployed advanced technologies in highly regulated pharmaceutical environments, gaining valuable insight into the decisions made, the challenges encountered and the measurable results achieved. From Rubedo Life Sciences’ use of data-driven agility to AGILOX Services GmbH’s deployment of autonomous mobile robotics to improve manufacturing efficiency, the agenda is centred on proven case studies that demonstrate how digital innovation can be translated into operational success.
A key highlight of the event will be a dedicated workshop led by Joachim Bär of Boehringer Ingelheim, offering attendees hands-on perspectives on digital plant modelling and exploring how these technologies can directly improve production efficiency while supporting long-term sustainability objectives.
Beyond the conference sessions themselves, AUTOMA+ places a strong emphasis on collaboration and networking. Structured meetings and discussion forums are designed to connect senior executives, technical specialists and operational leaders facing similar transformation challenges, creating opportunities to exchange knowledge, share best practice and establish valuable industry relationships.
As pharmaceutical manufacturers continue to modernise operations, successful digitalisation is no longer measured by the completion of pilot projects. Instead, it depends on an organisation’s ability to build scalable systems, embed change across the business and deliver tangible improvements in productivity, compliance and commercial performance.
For companies seeking to move beyond experimentation and into meaningful execution, AUTOMA+ 2026 offers a platform where strategy meets implementation and innovation is translated into measurable business outcomes.
Further information and registration details are available at: https://sh.bgs.group/4b4.